Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma
Clinical trial NCT05949931 · RECRUITING
Trial details
- NCT number
- NCT05949931
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2026-09-30
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.